A case of ketoacidosis caused by the breakdown of the infusion syringe during continuous subcutaneous insulin infusion-Reference-Cited by-同舟云学术

A case of ketoacidosis caused by the breakdown of the infusion syringe during continuous subcutaneous insulin infusion

Published:2012-03-30 Issue:3 Volume:3 Page:176-177
ISSN:2190-1678
Container-title:Diabetology International
language:en
Short-container-title:Diabetol Int

Author:

Izumi Kenichi,Mori Hitoe,Kojima Motoyasu,Takagi Yusuke,Kawata Nozomi,Yanagi Yui,Takagi Satoko,Nishimura Hiroko,Ashida Kenji,Hisatomi Akitaka,Anzai Keizo

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13340-012-0071-1.pdf

Reference10 articles.

1. Renard E, Guerci B, Leguerrier AM, Boizel R, Group A-CFS. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Diabetes Technol Ther. 2010;12:769–73.

2. Hughes CR, McDowell N, Cody D, Costigan C. Sustained benefits of continuous subcutaneous insulin infusion. Arch Dis Child. 2012;97(3):245–7.

3. Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, et al. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med. 2008;25:80–5.

4. Alemzadeh R, Parton EA, Holzum MK. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes. Diabetes Technol Ther. 2009;11:481–6.

5. Johannesen J, Eising S, Kohlwes S, Riis S, Beck M, Carstensen B, et al. Treatment of Danish adolescent diabetic patients with CSII—a matched study to MDI. Pediatr Diabetes. 2008;9:23–8.